Baseline demographic and clinical features
| Placebo | GM-CSF | |
| N | 21 | 17 |
| Median age, years (range) | 68 (31–80) | 69 (28–89) |
| Median body mass, kg (range) | 82 (45–144) | 77 (49–103) |
| % with a surgical reason for admission to ICU | 29 | 18 |
| Median APACHE II Score (IQR) | 21 (18–23) | 19.5 (16–27.5) |
| Sepsis on admission (n) | 9 | 8 |
| Median SOFA Score on admission (IQR) | 8 (6–10) | 9 (4–11) |
| Median lowest MAP, mm Hg (IQR) | 63 (61–66) | 61 (59.5–64.5) |
APACHE II, Acute Physiology and Chronic Health Evaluation II; GM-CSF, granulocyte-macrophage colony-stimulating factor; ICU, intensive care unit; SOFA, sequential organ failure assessment; MAP, mean arterial pressure.